Business Description
Phibro Animal Health Corp
NAICS : 311119
SIC : 742
ISIN : US71742Q1067
Share Class Description:
FRA:PB8: Class ADescription
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.9 | |||||
| Debt-to-EBITDA | 6.13 | |||||
| Interest Coverage | 2.77 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.45 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.9 | |||||
| 3-Year EBITDA Growth Rate | 1.4 | |||||
| 3-Year EPS without NRI Growth Rate | 0.2 | |||||
| 3-Year Book Growth Rate | 14.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 2.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 2.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.91 | |||||
| 9-Day RSI | 40.64 | |||||
| 14-Day RSI | 45.32 | |||||
| 6-1 Month Momentum % | 5.77 | |||||
| 12-1 Month Momentum % | -20.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.12 | |||||
| Quick Ratio | 1.6 | |||||
| Cash Ratio | 0.49 | |||||
| Days Inventory | 152.23 | |||||
| Days Sales Outstanding | 57.08 | |||||
| Days Payable | 42.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.85 | |||||
| Dividend Payout Ratio | 0.5 | |||||
| Forward Dividend Yield % | 3.85 | |||||
| 5-Year Yield-on-Cost % | 4.12 | |||||
| Shareholder Yield % | -1.97 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.4 | |||||
| Operating Margin % | 5.83 | |||||
| Net Margin % | 1.51 | |||||
| FCF Margin % | 3.75 | |||||
| ROE % | 5.41 | |||||
| ROA % | 1.53 | |||||
| ROIC % | 3.85 | |||||
| ROC (Joel Greenblatt) % | 8.37 | |||||
| ROCE % | 6.15 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 33.62 | |||||
| Forward PE Ratio | 10.17 | |||||
| PE Ratio without NRI | 12.94 | |||||
| Shiller PE Ratio | 8.61 | |||||
| Price-to-Owner-Earnings | 14.67 | |||||
| PS Ratio | 0.51 | |||||
| PB Ratio | 1.86 | |||||
| Price-to-Tangible-Book | 3.05 | |||||
| Price-to-Free-Cash-Flow | 13.61 | |||||
| Price-to-Operating-Cash-Flow | 6.78 | |||||
| EV-to-EBIT | 18.94 | |||||
| EV-to-Forward-EBIT | 15.19 | |||||
| EV-to-EBITDA | 11.05 | |||||
| EV-to-Revenue | 0.94 | |||||
| EV-to-Forward-Revenue | 0.87 | |||||
| EV-to-FCF | 24.97 | |||||
| Price-to-Projected-FCF | 1.38 | |||||
| Price-to-Median-PS-Value | 0.41 | |||||
| Price-to-Graham-Number | 1.32 | |||||
| Earnings Yield (Greenblatt) % | 5.28 | |||||
| FCF Yield % | 7.35 | |||||
| Forward Rate of Return (Yacktman) % | -0.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Phibro Animal Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 910.841 | ||
| EPS (TTM) (€) | 0.342 | ||
| Beta | 0.95 | ||
| Volatility % | 35.5 | ||
| 14-Day RSI | 45.32 | ||
| 14-Day ATR (€) | 0.252659 | ||
| 20-Day SMA (€) | 11.9 | ||
| 12-1 Month Momentum % | -20.86 | ||
| 52-Week Range (€) | 8.65 - 14.2 | ||
| Shares Outstanding (Mil) | 40.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Phibro Animal Health Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Phibro Animal Health Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Phibro Animal Health Corp Frequently Asked Questions
What is Phibro Animal Health Corp(FRA:PB8)'s stock price today?
The current price of FRA:PB8 is €11.50. The 52 week high of FRA:PB8 is €14.20 and 52 week low is €8.65.
When is next earnings date of Phibro Animal Health Corp(FRA:PB8)?
The next earnings date of Phibro Animal Health Corp(FRA:PB8) is 2024-05-03 Est..
Does Phibro Animal Health Corp(FRA:PB8) pay dividends? If so, how much?
The Dividend Yield %  of Phibro Animal Health Corp(FRA:PB8) is 3.85% (As of Today), Highest Dividend Payout Ratio of Phibro Animal Health Corp(FRA:PB8) was 0.57. The lowest was 0.2. And the median was 0.34. The  Forward Dividend Yield % of Phibro Animal Health Corp(FRA:PB8) is 3.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers